Main > A1. CORP. INDEX. A-Am No. 1 > AcelRx Pharmaceuticals Inc./P C2

---

AcelRx Pharmaceuticals Inc./P C2's subsections
2010. 04.06.2010. CEO
2010. 10.01.2010. ARX-02
2011. 05.31.2011. ARX-04
2011. 09.28.2011. Director
2012. 04.11.2012. Patent
2012. 04.17.2012. VP Reg Affairs &
2012. 08.01.2012. Patent
2012. 08.29.2012. Patent
2012. 09.18.2012. Chief Clin Affair
2013. 12.19. $40M Credit Facility
2014. 10.22. Post Surgery Pain
2018. 06.27. Pain
2020. 03.16. Acq. Tetraphase Pharma
2021. 07.14. Aguettant Licensing
2022. 01.10. Acq. Lowell Therapeuti
2022. 10.27. Pain>EU Launch
Web-Site

AcelRx Pharmaceuticals Inc./P C2's products
This section has no products